Literature DB >> 8333757

Corticosteroid treatment in cystic fibrosis.

J F Price1, P Greally.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8333757      PMCID： PMC1029359          DOI： 10.1136/adc.68.6.719

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  38 in total

1.  Recombinant human tumour necrosis factor (rTNF)2 enhances leukotriene biosynthesis in neutrophils and eosinophils stimulated with the Ca2+ ionophore A23187.

Authors:  R Roubin; P P Elsas; W Fiers; A J Dessein
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

2.  Risks of alternate-day prednisone in patients with cystic fibrosis.

Authors:  B J Rosenstein; H Eigen
Journal:  Pediatrics       Date:  1991-02       Impact factor: 7.124

Review 3.  Effects of glucocorticosteroids on inflammatory cells relevant to their therapeutic applications in asthma.

Authors:  R P Schleimer
Journal:  Am Rev Respir Dis       Date:  1990-02

Review 4.  Interactions of Pseudomonas aeruginosa proteases with the cells of the immune system.

Authors:  A Kharazmi
Journal:  Antibiot Chemother (1971)       Date:  1989

5.  Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections.

Authors:  R W Wilmott; J T Kassab; P L Kilian; W R Benjamin; S D Douglas; R E Wood
Journal:  Am Rev Respir Dis       Date:  1990-08

6.  Inhibition of eicosanoid biosynthesis by glucocorticoids in humans.

Authors:  R J Sebaldt; J R Sheller; J A Oates; L J Roberts; G A FitzGerald
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

7.  Human alveolar macrophage gene expression of interleukin-8 by tumor necrosis factor-alpha, lipopolysaccharide, and interleukin-1 beta.

Authors:  R M Strieter; S W Chensue; M A Basha; T J Standiford; J P Lynch; M Baggiolini; S L Kunkel
Journal:  Am J Respir Cell Mol Biol       Date:  1990-04       Impact factor: 6.914

8.  Relation between tumor necrosis factor-alpha and granulocyte elastase-alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis.

Authors:  S Suter; U B Schaad; P Roux-Lombard; E Girardin; G Grau; J M Dayer
Journal:  Am Rev Respir Dis       Date:  1989-12

9.  Serum leukotriene B4 levels in patients with obstructive pulmonary disease.

Authors:  J S Seggev; W H Thornton; T E Edes
Journal:  Chest       Date:  1991-02       Impact factor: 9.410

10.  Sputum tumour necrosis factor-alpha and leukotriene concentrations in cystic fibrosis.

Authors:  P Greally; M J Hussein; A J Cook; A P Sampson; P J Piper; J F Price
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791
View more
  1 in total

1.  Cytokines in neutrophil-dominated airway inflammation in patients with cystic fibrosis.

Authors:  A Schuster; A Haarmann; V Wahn
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.